Short answer
Aquestive Therapeutics, Inc. (AQST) filed an 8-K current report with the SEC on September 25, 2026 reporting Item 7.01 (Regulation FD Disclosure). Investor presentation furnished under Regulation FD for institutional investor and analyst meetings.
Aquestive Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Investor presentation furnished under Regulation FD for institutional investor and analyst meetings
- Presentation content may be amended or updated through subsequent filings or other disclosures
- Exhibit 99.1 contains the substantive investor materials and likely market-relevant details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aquestive Therapeutics, Inc. 8-K filings
Get the next AQST 8-K as it lands
Follow AQST for push alerts, or ask the research agent what this filing means.